Home
Categories
Ingredients
Analysis
Manufacturing
Finance
Regulatory
Drug Delivery
Research & Development
Sustainability
Pharma 5.0
Company News
Events
Directory
Search
Close search
Home
Company
Nestle Group
Nestle Group
Activities:
Active Nutrition
Food
Nutraceutical
X
LinkedIn
Trending Articles
Agilent boosts contract manufacturing capabilities with acquisition of BIOVECTRA
The CDMO acquisition will bolster Agilent's end-to-end production capabilities in a number of popular therapeutics, including GLP-1 medications and ADCs
Therapeutic: ensifentrine for chronic obstructive pulmonary disease
Chronic obstructive pulmonary disease (COPD) comes in various guises, including chronic bronchitis and emphysema; and, although incurable, the symptoms can be managed with...
Merck’s clesrovimab meets all primary endpoints in Phase IIb/III trial for RSV in infants
A teaser of the Phase IIb/III trial released by Merck indicates that clesrovimab can reduce the need to medically attend lower respiratory infections caused by RSV in infants
Bringing biotech to the Baltics: the rise of Lithuania
Lithuania’s biotechnology competencies lie in cell and gene therapies, enzymes and the wider pharmaceutical industry, offering companies a rich pool of talent in a...
Currax to build novel anti-obesity treatment production facility amidst GLP-1 supply issues
The manufacturing facility will be dedicated to the production of anti-obesity drug Contrave, and will double its output in the EU and EEA
Upcoming event
ISPE Singapore
28-30 August 2024 | Conference and exhibition | Singapore
See all
Related Content
Ingredients
Nestlé tackles phenylketonuria with Codexis enzyme
Codexis announces that Nestlé Health Science has exercised its option to obtain an exclusive license for the global development and commercialisation of the orally delivered enzyme CDX-6114 for the management of phenylketonuria (PKU)
Ingredients
Nestlé agrees joint venture with China MediTech
NSP will develop nutritional and medical products derived from botanical plants
Finance
Nestlé Health Science to buy Prometheus Laboratories
Makes a strategic move into gastrointestinal diagnostics
Finance
Novartis and Alcon agree merger terms
Will create a new eyecare group with Ciba Vision and ophthalmic medicines business
Novartis to buy rest of Alcon
<p>Swiss pharmaceutical group Novartis is to purchase 52% of eye care specialist Alcon from Nestle in the second stage of a US$38.5bn deal agreed in 2008.</p>
Media
Alcon to acquire ESBATech
<p>Eye care specialist Alcon is to acquire Swiss biotechnology company ESBATech, based in Zurich, for US$150m in cash.</p>
Subscribe now